Vertex Pharmaceuticals
VRTX
#175
Rank
S$156.66 B
Marketcap
S$616.71
Share price
1.33%
Change (1 day)
-4.39%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): S$5.84 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are S$11.72 Billion. In 2024 the company made an earning of S$0.35 Billion a decrease over its 2023 earnings that were of S$5.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$5.84 B1556.3%
2024 S$0.35 B-93.69%
2023 S$5.59 B3.19%
2022 S$5.42 B53.56%
2021 S$3.53 B-12.06%
2020 S$4.01 B118.45%
2019 S$1.83 B120.64%
2018 S$0.83 B1473.64%
2017 S$52.96 M197.6%
2016 S$17.79 M-102.97%
2015 -S$0.6 Billion-28.46%
2014 -S$0.84 Billion-51.5%
2013 -S$1.73 Billion-30584.68%
2012 S$5.66 M-95.47%
2011 S$0.12 B
2009 -S$0.75 Billion
2007 -S$0.53 Billion83.1%
2006 -S$0.29 Billion59.02%
2005 -S$0.18 Billion3.28%
2004 -S$0.18 Billion-38.16%
2003 -S$0.29 Billion
2000 -S$48.14 Million-20.38%
1999 -S$60.45 Million31.62%
1998 -S$45.93 Million91.05%
1997 -S$24.04 Million-36.24%
1996 -S$37.71 Million12.45%
1995 -S$33.53 Million27.4%
1994 -S$26.32 Million-1833.33%
1993 S$1.51 M-112.12%
1992 -S$12.53 Million175%
1991 -S$4.56 Million-12.2%
1990 -S$5.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$40.98 B 626.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$2.10 B-62.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$12.50 B 121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.21 B 417.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.16 B 80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-S$95.99 Million-101.70%๐Ÿ‡บ๐Ÿ‡ธ USA